Eliquis lowers stroke, major bleeding in older non-valvular AF patients

Bristol-Myers Squibb Co. (NYSE:BMY) and Pfizer Inc. (NYSE:PFE) said a real-world analysis of U.S. patients ages >65 with non-valvular atrial fibrillation (AF) showed that Eliquis apixaban (BMS-562247-01) significantly reduced the risk of

Read the full 328 word article

How to gain access

Continue reading with a
two-week free trial.